Royal Bank of Canada
WINT

Royal Bank of Canada’s Windtree Therapeutics Inc WINT Stock Holding History

Royal Bank of Canada’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-28
Closed – – 7077
2017
Q1 		$0 Hold
28
– – ﹤0.01% 7012
2016
Q4 		$0 Hold
28
– – ﹤0.01% 6937
2016
Q3 		$0 Hold
28
– – ﹤0.01% 6747
2016
Q2 		$0 Hold
28
– – ﹤0.01% 6701
2016
Q1 		$0 Sell
28
-1
-3% -$2 ﹤0.01% 6911
2015
Q4 		$0 Hold
29
– – ﹤0.01% 7044
2015
Q3 		$0 Hold
29
– – ﹤0.01% 6925
2015
Q2 		$0 Buy
+29
New +$407 ﹤0.01% 6846

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Royal Bank of Canada's WINT Position: Q2 2017 in Review

Royal Bank of Canada sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 28 shares.

Royal Bank of Canada first reported a position in WINT in Q2 2015 and held it in 8 quarters. The position peaked at $0 in Q1 2017. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Royal Bank of Canada reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Royal Bank of Canada sold 28 Windtree Therapeutics Inc shares in Q2 2017.
  • Royal Bank of Canada first reported a position in Windtree Therapeutics Inc in Q2 2015 and held it in 8 quarters.
  • Royal Bank of Canada's Windtree Therapeutics Inc position peaked at $0 in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Royal Bank of Canada's 13F filing for Q2 2017, filed 14 Aug 2017.